tradingkey.logo

Bionano Genomics Inc

BNGO
1.150USD
+0.025+2.22%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
11.19MCap. mercado
PérdidaP/E TTM

Bionano Genomics Inc

1.150
+0.025+2.22%

Más Datos de Bionano Genomics Inc Compañía

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Información de Bionano Genomics Inc

Símbolo de cotizaciónBNGO
Nombre de la empresaBionano Genomics Inc
Fecha de salida a bolsaAug 01, 2018
Director ejecutivoHolmlin (R. Erik)
Número de empleados98
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 01
Dirección9540 Towne Centre Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Teléfono18588887600
Sitio Webhttps://bionano.com/
Símbolo de cotizaciónBNGO
Fecha de salida a bolsaAug 01, 2018
Director ejecutivoHolmlin (R. Erik)

Ejecutivos de Bionano Genomics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-59.00%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-7.00%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-1.00%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-91.00%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-59.00%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-7.00%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-1.00%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-91.00%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%
Por regiónUSD
Nombre
Ganancia
Proporción
EMEIA
3.63M
49.30%
Americas
2.85M
38.62%
Asia Pacific
890.00K
12.08%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%

Estadísticas de accionistas

Actualizado: sáb., 7 de feb
Actualizado: sáb., 7 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
GSA Capital Partners LLP
3.32%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
Otro
81.77%
Accionistas
Accionistas
Proporción
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
GSA Capital Partners LLP
3.32%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
Otro
81.77%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
6.35%
Hedge Fund
5.39%
Corporation
5.16%
Individual Investor
3.19%
Investment Advisor/Hedge Fund
0.37%
Research Firm
0.10%
Otro
79.44%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
123
914.11K
2.31%
--
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
2023Q3
336
90.39K
20.40%
+284.00
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Lincoln Alternative Strategies LLC
525.00K
5.16%
+525.00K
--
Sep 17, 2025
Heights Capital Management, Inc.
475.00K
4.67%
+475.00K
--
Sep 16, 2025
Abbe (Richard)
322.53K
3.17%
+322.53K
--
Sep 30, 2025
Iroquois Capital Management, LLC
194.66K
1.91%
+194.66K
--
Sep 30, 2025
The Vanguard Group, Inc.
50.46K
0.5%
+50.46K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
26.84K
0.26%
+7.97K
+42.22%
Sep 30, 2025
Carret Asset Management, LLC
25.00K
0.25%
+25.00K
--
Sep 30, 2025
HRT Financial LP
20.33K
0.2%
+20.33K
--
Sep 30, 2025
Two Sigma Investments, LP
15.58K
0.15%
+15.58K
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0%
Avantis US Small Cap Equity ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI